T

Teradan Clinical Trials | Brandon, FL

Research site
(Unclaimed)
Location
910 Oakfield Drive, Brandon, Florida, United States of America
Site insights

Top conditions

Obstructive Sleep Apnea (6 trials)

COVID-19 (4 trials)

Sleep Apnea Syndromes (4 trials)

Obesity (3 trials)

Apnea (3 trials)

Top treatments

Retatrutide
LY3437943
AD504
Abivertinib Maleate
SUVN-G3031
Ruxolitinib
Atomoxetine
STI-2020
STI-5656
R-oxybutynin

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

8 of 16
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥50 Years of Age (RSVictory)

The main purposes of Part A of this study are to evaluate the safety, tolerability, and immunogenicity of mRNA-1345 coadministered with a seasonal in...

Active, not recruiting
Respiratory Syncytial Virus
Biological: mRNA-1273.214
Biological: mRNA-1345
Locations recently updated

The purpose of this study is to evaluate the efficacy and safety of retatrutide in participants who have obesity or overweight (J1I-MC-GZBJ master pr...

Enrolling
Overweight
Knee Pain Chronic
Drug: Retatrutide
Drug: Placebo
Locations recently updated

The purpose of this study is to is to evaluate the efficacy and safety of retatrutide in participants with type 2 diabetes in participants who have o...

Enrolling
Overweight
Obesity
Drug: Placebo
Drug: Retatrutide

This study assesses the efficacy, safety, and pharmacokinetics of multiple-dose oral administration of daridorexant in pediatric subjects aged 10 to...

Enrolling
Insomnia
Drug: Daridorexant 50 mg
Drug: Daridorexant 10 mg

The purpose of this study is to evaluate the effect and safety of tirzepatide in participants with obstructive sleep apnea and obesity who are both u...

Active, not recruiting
Obesity
Sleep Apnea
Drug: Tirzepatide
Drug: Placebo

This is a Phase 3 Randomized Double-Blind Placebo-Controlled 1-year Parallel-Arm Study to Compare a Fixed Dose Combination of AD109 to Placebo in Obs...

Enrolling
OSA
Drug: Placebo
Drug: AD109

This is a Phase 2 study to assess COVI-MSC in the setting of current standard of care in hospitalized subjects with RT-PCR confirmed SARS-CoV-2 (COVI...

Enrolling
Covid19
Drug: Placebo
Biological: COVI-MSC

The purpose of this study is to evaluate the safety, efficacy, pharmacokinetics (PK), and pharmacodynamics (PD) of MK-6552 in participants with Narco...

Enrolling
Narcolepsy
Drug: MK-6552
Drug: Placebo

Trial sponsors

A

Apnimed (3 trials)

Lilly logo

Lilly (3 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems